US Patent 7550484 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
Patent 7550484 was granted and assigned to Genzyme on June, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+355 characters)
Article
Patent abstract
Compounds that interact with the CXCR4 receptor are described. These compounds are useful in treating, for Example, HIV infection and inflammatory conditions such as rheumatoid arthritis, as well as asthma or cancer, and are useful in methods to elevate progenitor and stem cell counts as well as methods to elevate white blood cell counts.
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07550484 Chemokine receptor binding heterocyclic compounds with enhanced efficacy US Patent 7550484 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
Infobox
Patent Number
0755048400
Patent Number
755048400
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075504840
Date of Patent
June 23, 2009
0Patent Application Number
108310980
Date Filed
April 22, 2004
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075504840
Date of Patent
June 23, 2009
0Patent Application Number
108310980
Date Filed
April 22, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07550484 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07550484
Date of patent
June 23, 2009
Patent application number
10831098
Date Filed
April 22, 2004
Patent primary examiner
Find more entities like US Patent 7550484 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.